Skip to main content
Dyann F. Wirth
Primary Faculty

Dyann F. Wirth

Richard Pearson Strong Professor of Infectious Diseases

Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health

Departments

Department of Immunology and Infectious Diseases

Biography

Protozoan parasites remain major causes of disease in developing countries throughout the world, yet little is known about the biology or molecular biology of these organisms. The long term goal of this work is to understand basic molecular mechanisms in protozoan parasites with the goal of discovering and applying parasite specific interventions.

The approach my laboratory has taken is to develop methods for molecular genetic manipulation of protozoan parasites in order to begin functional analysis of genes important for parasite virulence, with an emphasis of mechanisms of drug resistance in parasites. Drug resistance poses a particularly difficult problem in developing countries where newer chemotherapeutic agents are often unavailable or too expensive for routine use. Drug resistance is particularly acute in malaria where resistant parasites have spread throughout the endemic world.

Recent evidence from my laboratory and from several other groups worldwide has suggested that a major mechanism of drug resistance in protozoan parasites may be through the expression of a P-glycoprotein type molecule encoded by a multi-drug resistance gene. Genes related to mammalian multi-drug resistance genes have been identified in several protozoan parasites and overexpression of these genes is associated with drug resistance. The immediate goal of the research is to test the hypothesis that these mdr-like genes are indeed the cause of drug resistance in protozoan parasites. This work has been initiated in the Leishmania parasite where my laboratory has previously developed a transfection system, and thus the role of the Leishmania enriettii mdr-like genes can be directly tested.

In parallel, my laboratory has recently developed an analogous transfection system for the malaria parasite. By analyzing these two protozoan systems in parallel, one where the molecular tools are readily available and the other in which drug resistant parasites represent a major and immediate threat to world health, I hope both to understand the mechanism of drug resistance in protozoan parasites and to use this information to develop new approaches to either preventing or reversing drug resistance in these organisms.

Executive Assistant: Haley Cronshaw, hcronshaw@hsph.harvard.edu

Education and Training

  • B.A. ,
    University of Wisconsin
  • Ph.D.,
    Massachusetts Institute of Technology

Awards and Honors

  • Alice and C.C. Wang Award in Molecular Parasitology, 2022
    he American Society for Biochemistry and Molecular Biology
  • Walter Reed Medal , 2021
    American Society of Tropical Medicine and Hygiene
  • Honorary Fellow, 2019
    American Association for the Advancement of Science
  • Lifetime Achievement Award, 2018
    BioMalPar
  • Faculty Mentoring Award, 2016
    Committee on the Advancement of Women Faculty (CAWF), Harvard T.H. Chan School of Public Health
  • Fellow, 2016
    American Society of Tropical Medicine and Hygiene
  • Joseph Augustin LePrince Medal, 2015
    American Society of Tropical Medicine and Hygiene
  • Fellow, 2010
    American Academy of Microbiology
  • Member, 2004
    Institute of medicine of the National Academies
  • President, 1998 - 1999
    American Society of Tropical Medicine and Hygiene
  • Bailey K. Ashford Award, 1995
    American Society of Tropical Medicine and Hygiene
  • Award in Molecular Parasitology, 1985 - 1990
    Burroughs Wellcome
  • Award in Molecular Parasitology, 1982
    Burroughs Wellcome
  • Fellowship, 1978 - 1981
    Helen Hay Whitney
  • Predoctoral Fellowship, 1973 - 1978
    National Institutes of Health
  • Fellow, 1972 - 1973
    Fulbright Foundation
  • Phi Beta Kappa, 1972
  • B.A. with Highest Honors, 1972
    University of Wisconsin, Madison

Publications

  • In vivo screen of Plasmodium targets for mosquito-based malaria control.

    Probst AS, Paton DG, Appetecchia F, Bopp S, Adams KL, Rinvee TA, Pou S, Winter R, Du EW, Yahiya S, Vidoudez C, Singh N, Rodrigues J, Castañeda-Casado P, Tammaro C, Chen D, Godinez-Macias KP, Jaramillo JL, Poce G, Rubal MJ, Nilsen A, Winzeler EA, Baum J, Burrows JN, Riscoe MK, Wirth DF, Catteruccia F. Nature 2025 May 21
    PMID: 40399670
  • Revisiting the Plasmodium falciparum druggable genome using predicted structures and data mining.

    Godinez-Macias KP, Chen D, Wallis JL, Siegel MG, Adam A, Bopp S, Carolino K, Coulson LB, Durst G, Thathy V, Esherick L, Farringer MA, Flannery EL, Forte B, Liu T, Godoy Magalhaes L, Gupta AK, Istvan ES, Jiang T, Kumpornsin K, Lobb K, McLean KJ, Moura IMR, Okombo J, Payne NC, Plater A, Rao SPS, Siqueira-Neto JL, Somsen BA, Summers RL, Zhang R, Gilson MK, Gamo FJ, Campo B, Baragaña B, Duffy J, Gilbert IH, Lukens AK, Dechering KJ, Niles JC, McNamara CW, Cheng X, Birkholtz LM, Bronkhorst AW, Fidock DA, Wirth DF, Goldberg DE, Lee MCS, Winzeler EA. NPJ Drug Discov 2025
    PMID: 40066064
  • MalKinID: A classification model for identifying malaria parasite genealogical relationships using identity-by-descent.

    Wong W, Wang L, Schaffner SF, Li X, Cheeseman I, Anderson TJC, Vaughan A, Ferdig M, Volkman SK, Hartl DL, Wirth DF. Genetics 2025 Feb 05
    PMID: 39579070
  • Systematic in vitro evolution in Plasmodium falciparum reveals key determinants of drug resistance.

    Luth MR, Godinez-Macias KP, Chen D, Okombo J, Thathy V, Cheng X, Daggupati S, Davies H, Dhingra SK, Economy JM, Edgar RCS, Gomez-Lorenzo MG, Istvan ES, Jado JC, LaMonte GM, Melillo B, Mok S, Narwal SK, Ndiaye T, Ottilie S, Palomo Diaz S, Park H, Peña S, Rocamora F, Sakata-Kato T, Small-Saunders JL, Summers RL, Tumwebaze PK, Vanaerschot M, Xia G, Yeo T, You A, Gamo FJ, Goldberg DE, Lee MCS, McNamara CW, Ndiaye D, Rosenthal PJ, Schreiber SL, Serra G, De Siqueira-Neto JL, Skinner-Adams TS, Uhlemann AC, Kato N, Lukens AK, Wirth DF, Fidock DA, Winzeler EA. Science 2024 11 29
    PMID: 39607932
  • Revisiting the Plasmodium falciparum druggable genome using predicted structures and data mining.

    Godinez-Macias KP, Chen D, Wallis JL, Siegel MG, Adam A, Bopp S, Carolino K, Coulson LB, Durst G, Thathy V, Esherick L, Farringer MA, Flannery EL, Forte B, Liu T, Magalhaes LG, Gupta AK, Istvan ES, Jiang T, Kumpornsin K, Lobb K, McLean K, Moura IMR, Okombo J, Payne NC, Plater A, Rao SPS, Siqueira-Neto JL, Somsen BA, Summers RL, Zhang R, Gilson MK, Gamo FJ, Campo B, Baragaña B, Duffy J, Gilbert IH, Lukens AK, Dechering KJ, Niles JC, McNamara CW, Cheng X, Birkholtz LM, Bronkhorst AW, Fidock DA, Wirth DF, Goldberg DE, Lee MCS, Winzeler EA. Res Sq 2024 Nov 26
    PMID: 39649165